Agilent Technologies
AGILENT TECHNOLOGIES, INC.
Key figures
Period Nov 2024 to Oct 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$6.9B
Operating marginCalculated
21.3%
Net assets to total assetsCalculated
53.0%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★★★position among all companies
21.3%
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
2.4%
Capital efficiency
★★★★☆position among all companies
19.3%
Revenue and profit
Performance, financial position and capital allocation
Agilent Technologies
Recent performance trends
Agilent Technologies
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$6.3 billion | US$6.8 billion | US$6.8 billion | US$6.5 billion | US$6.9 billion |
| Operating income | US$1.3 billion | US$1.6 billion | US$1.4 billion | US$1.5 billion | US$1.5 billion |
| Net income | US$1.2 billion | US$1.3 billion | US$1.2 billion | US$1.3 billion | US$1.3 billion |
| Total assets | US$10.7 billion | US$10.5 billion | US$10.8 billion | US$11.8 billion | US$12.7 billion |
| Shareholders' equity | US$5.4 billion | US$5.3 billion | US$5.8 billion | US$5.9 billion | US$6.7 billion |
| Net cash provided by (used in) operating activities | US$1.5 billion | US$1.3 billion | US$1.8 billion | US$1.8 billion | US$1.6 billion |
| Net cash provided by (used in) investing activities | US$-0.7 billion | US$-0.3 billion | US$-0.3 billion | US$-1.3 billion | US$-0.4 billion |
| Net cash provided by (used in) financing activities | US$-0.7 billion | US$-1.4 billion | US$-0.9 billion | US$-0.8 billion | US$-0.7 billion |
| Cash and cash equivalents | US$1.5 billion | US$1.1 billion | US$1.6 billion | US$1.3 billion | US$1.8 billion |
Revenue scale in the same industry
Agilent Technologies
Instruments and medical devices: 43 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Thermo Fisher ScientificFY Dec 2025 US$44.6B
- 2 Northrop Grumman Corp /DE/FY Dec 2025 US$42.0B
- 3 MedtronicFY Apr 2026 US$36.4B
- … 16 companies
- 20 GarminFY Dec 2025 US$7.2B
- 21 CoherentFY Jun 2026 US$7.1B
- 22 Agilent TechnologiesThis companyFY Oct 2025 US$6.9B
- 23 AvantorFY Dec 2025 US$6.6B
- 24 Teledyne TechnologiesFY Dec 2025 US$6.1B
- … 19 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.4 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$1.8 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.7 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$1.6 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.3 billion | Consolidated | Disclosed |
| Dividends paid | US$0.3 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$-0.2 billion | Consolidated | Disclosed |
| Net assets | US$6.7 billion | Consolidated | Disclosed |
| Net sales | US$6.9 billion | Consolidated | Disclosed |
| Operating income | US$1.5 billion | Consolidated | Disclosed |
| Net income | US$1.3 billion | Consolidated | Disclosed |
| Total assets | US$12.7 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.4 billion | Consolidated | Disclosed |
| Operating margin | 21.3% | Consolidated | Calculated |
| Net assets to total assets | 53.0% | Consolidated | Calculated |
| Net margin | 18.8% | Consolidated | Calculated |
| Return on equity | 19.3% | Consolidated | Calculated |